Formoterol + Glycopyrronium
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Formoterol
formoterol - Glycopyrronium
glycopyrronium
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| Bevespi Aerosphere 7.2micrograms/dose / 5micrograms/dose pressurised inhalerGB | — | AstraZeneca UK Ltd |
| Glycopyrronium 7.2micrograms/dose / Formoterol 5micrograms/dose inhaler CFC freeGB | — | AstraZeneca UK Ltd |
| GLYCOPYRRONIUM / FORMOTEROL FUMARATE DIHYDRATE PRESSURIZEDCA | 0.0083 mg / 0.0058 mg | ASTRAZENECA CANADA INC |
| 必肺宜氣化噴霧劑7.2/5.0微克/劑量TW | — | 臺灣阿斯特捷利康股份有限公司 |
| Bevespi Aerosphere 7.2/5.0 micrograms Pressurised Inhalation, SuspensionTW | — | 臺灣阿斯特捷利康股份有限公司 |
| TRIMBOW PRESSURISED INHALATION, SOLUTION 87MCG/5MCG/9MCGHK | — | ZENFIELDS (H.K.) LIMITED |
| BEVESPI AEROSPHERE 7.2/5 glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg per actuation inhalation pressurised metered dose inhalerAU | 5 microgram/actuation / 9 microgram/actuation | AstraZeneca Pty Ltd |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
Only the main ingredient is the same — this is NOT the same fixed-dose combination. View the main ingredient
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.